Germany's BioNTech and US pharma giant Pfizer said Friday they had suffered a setback in a late-stage trial of their combined mRNA vaccine against
Germany’s BioNTech and US pharma giant Pfizer said Friday they had suffered a setback in a late-stage trial of their combined mRNA vaccine against COVID-19 and influenza. In a phase 3 trial, the combo vaccine showed a stronger immune response against the influenza A strain than against the less common influenza B strain. Against COVID, […]
The post Pfizer-BioNTech’s Covid-flu jab disappoints in trial appeared first on Insider Paper.
https://insiderpaper.com/pfizer-biontechs-covid-flu-jab-disappoints-in-trial/
Comments
0 comment